Jayanth Doss is a Rheumatology/Immunology physician affiliated with Duke University. OpenAlex indexes 64 publications with 340 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
40 Duke Medicine Cir
#1j
Durham, NC 277104000
Telephone
919-668-7400Registry record last updated 1 Jul 2015.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- Janssen Biotech, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
39.4%Folate Analog Metabolic Inhibitor15.8%Methotrexate96%Methotrexate Sodium4%Part D<11 patientsTNF inhibitor10.1%Enbrel Sureclick42%Enbrel26%Humira(Cf) Pen26%Cimzia (2 Pack)6%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
22.8%Corticosteroid18.9%Prednisone100%Part D≥122 patientsProton pump inhibitor2.8%Omeprazole75%Pantoprazole Sodium26%Part D<11 patients+ 1 more class in this area
Antiparasitic
15.4%Antimalarial15.4%Hydroxychloroquine Sulfate100%Part D≥106 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A NOVEL MODELING APPROACH TO ELUCIDATE THE ROLE OF AUTOANTIBODIES IN COMPLEMENT ACTIVATION IN SLE
The Journal of Rheumatology
2025 - CHARACTERISTICS OF PATIENTS WITH INTERMITTENT AND PERSISTENT TYPE 2 SLE
The Journal of Rheumatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Califf, MD
Duke University
Pamela Douglas, MD
Duke University
Adrian Hernandez, MD
Duke University
John Perfect, MD
Duke University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”